Send us a text We welcome back Professor Tom Crosby for another episode on oesophageal cancer. In the previous episode we focus on the diagnostic pathway. In this episode we look at option in the metastatic and advanced setting.
All content for Simply Oncology is the property of John McGrane & Michael Rowe and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text We welcome back Professor Tom Crosby for another episode on oesophageal cancer. In the previous episode we focus on the diagnostic pathway. In this episode we look at option in the metastatic and advanced setting.
Send us a text We welcome back Professor Tom Crosby for another episode on oesophageal cancer. In the previous episode we focus on the diagnostic pathway. In this episode we look at option in the metastatic and advanced setting.
Send us a text Join us this week as we hear Professor Tom Crosby share his insights into Oesophageal Cancer. Few people have been so highly regarded or associated with a cancer type like Tom Crosby and Oesophago-Gastric cancer. He has set up and run crucial trials, championed equity
Send us a text Join us for this weeks episode where we discuss the role of PSMA PET scanning in prostate cancer with Dr Amar Challapalli. PSMA PET scanning in prostate cancer has been a game changer in both diagnosis and treatment. We explore its role in the post-prostatectomy space. We look at how PSMA Lutetium offers a new treatment option in prostate cancer.
Send us a text Join us as we return with another special episode with Professor Alison Birtle. This time we discuss Upper Tract Urothelial (or ureteric) Cancer. Alison is an internationally recognised expert in this area and was lead on the POUT adjuvant chemotherapy in ureteric cancer trial. She describes it as the non-identical twin to bladder urothelial cancer and we discuss the different approaches to this rare cancer. Described as 'The Queen of Upper Tract Urothelial Cancer' she sh...
Send us a text 🚨May is Bladder Cancer Awareness Month 🎙️What better way to mark this than a Simply Oncology Podcast - Bladder Cancer episode with the irrepressible Professor Alison Birtle. Alison is an internationally recognised expert in bladder and prostate cancer - and is a Simply Oncology Friend of the Show. 🎙️We discuss the recent peri-operative trials such as NIAGARA 🎙️What do surgical adjuvant and neoadjuvant trails now mean for the bladder cancer pathway?
Send us a text 🤔Do you know your Cancer of Unknown Primary from your Malignancy of Unknown Origin. 🤔Do you think World CUP Alliance is a football tournament? Cancer of unknown primary is the 6th most common cause of cancer death in the UK 🎙️Find out with Dr Natalie Cook from The Christie Hospital who is a UK expert in CUP.
Send us a text Part 2 of our discussion on bladder cancer with Professor Rob Jones. We have new drug classes in Bladder cancer !! We look at Erdafitinib which is coming in the post Immunotherapy space to NHS England. We also look ahead to Antibody Drug Conjugates - in particular Enfortumab Vedotin - with EV 302 trial results and what access to this means for the UK bladder community. These are exciting times and we discuss potential side effects of these classes of drugs and how we inte...
Send us a text The Royal College of Radiologists celebrates 50 years of Royal Charter this year!!! Join us as we explore 50 years of the RCR Royal Charter with the President - Dr Katharine Halliday and Vice President - Dr Tom Roques. We look at the achievements of the Royal College of Radiologists have made over the years and look to the future of cancer care at the RCR. We hear how the RCR is our voice as a community of Radiologists and Oncologists. It guides our learning and sets the standa...
Send us a text Join us for this Simply Oncology is Back in Bladder Cancer with the amazing Prof Rob Jones. Part 1 of 2 on a free ranging overview of metastatic bladder cancer treatment in the UK. Cisplatin vs Carboplatin Role of IO 2nd line chemo?
Send us a text Join us for this episode where we explore Head and Neck cancers and their treatment. This is a group of cancers from the mouth to the vocal cords and make up the 8th most common group of cancers in the UK. Almost 13000 cases happen each year in the UK. We discuss the major role that radiotherapy plays and the process and side effects. Teamwork is a major component of Head and Neck cancer therapy. We also discuss how immunotherapy has a role in advanced Head & Neck cancer. A...
Send us a text Join us for the first part of this 2 part masterclass in breast radiotherapy. Breast radiotherapy is a major component of breast cancer treatment. It forms a large part of all radiotherapy delivered across cancer centres. After removal of a breast tumour radiotherapy is offered to reduce the chance of local relapse of the cancer. We talk to Professor Mark Beresford who is chair of the UK Breast Group about how breast radiotherapy has gone from 5 weeks of treatment to 1 week. We...
Send us a text Welcome back for our 2nd part of our radiotherapy update on breast cancer. We finish our discussion with Professor Mark Beresford who is Chair of the UK Breast Group. We discuss the timing of radiotherapy around breast reconstruction. We look at situations where we treat other areas such and above the collar bone (supraclavicular) or central area (internal mammary) areas. We examine when radiotherapy may be offered after mastectomy. We also look at when we may be able to avoid ...
Send us a text Join us for the 2nd part of our discussion with Dr Olubukola (Bookie) Ayodele on health inequities in cancer care. We look at potential steps to promote health equity. Bookie introduces the concept of 'Cultural Competency' in helping health professionals discuss the very challenging topic that is cancer. We hear how biological difference in blood results can play role in excluding back patients from certain chemotherapy trials. We think about the stepwise change and education n...
Send us a text Join us for this Simply Oncology podcast episode on Health Inequites in the UK with Dr Olubukola Ayodele. 🎙️We discuss the challenges in delivering equitable cancer care across all patients in the UK. 🎙️we hear a recent report stating that black women with breast cancer have 30%higher mortality than equivalent Caucasian women in theUK! 🎙️This is not just an issue for low and middle income countries. We need to Mind the Gap and Bridge the Gap.
Send us a text Join us for our second part of our discussions with the excellent Professor Ananya Choudhury where we discuss the option of bladder preserving treatment in muscle invasive bladder cancer. In this episode we hear Ananya's views on new Antibody Drug Conjugate trials being used as an alternative to radiotherapy in a bladder 'preservation' strategy. She is clear that this is experimental only at this stage and does not meet any true definition of bladder preservation in her view. A...
Send us a text Join us for this episode focusing on the role of radiotherapy in the treatment of bladder cancer. We talk to leading bladder radiotherapy expert Professor Ananya Choudhury. Ananya is passionate about all things bladder cancer related and discusses her views on bladder preservation and radiotherapy. She makes a strong case for bladder radiotherapy in muscle invasive bladder cancer versus surgery and we review the evidence. We also talk about the use of 'plan of the day' and on s...
Send us a text Join us in this second part of discussing resilience and burnout and oncology with Professor Susana Banerjee. In our last episode we looked at the ESMO Resilience Taskforce and what institutions should do to improve resilience. In this episode we discuss what can help us on an individual level. A lot of it comes down to a feeling of job satisfaction. That can be having some variety to maintain interest and keeping the parts of the job that we value at our core. Susie shares som...
Send us a text Burnout in oncology and throughout healthcare is a major issue. An ESMO survey conducted in young Oncologists in 2013-2014 revealed 70% of young oncologists in Europe were impacted by burnout. 25% of oncologists surveyed were thinking of a change of career and 38% of leaving the profession. All this at a time of needing more oncologists! Join us in this 2 part episode where we join the superb Professor Susana Banerjee. She discusses the issue of burnout and the exce...
Send us a text Join us for this special episode of the Simply Oncology Podcast. We have special guest Dr Tom Roques who is the Vice-President of the Royal College of Radiologists and lead for Clinical Oncology. Tom speaks candidly and clearly on ; - the challenges facing oncology - the opportunities AI may bring in oncology - the clinical oncology model - the role of the RCR in shaping UK oncology Enjoy
Send us a text Join us for this episode of Simply Oncology where we discuss how to become an oncologist. Oncology is always a forward thinking and progressive speciality and this involves training and developing training people to meet that challenge. We talk to Dr Louise Hanna who is an oncologist who treats gynaecological cancers at Velindre Hospital in Cardiff. She is also the Medical Director, Education and Training (MDET) for the Royal College of Radiologist (RCR). We discuss the appeal ...
Send us a text We welcome back Professor Tom Crosby for another episode on oesophageal cancer. In the previous episode we focus on the diagnostic pathway. In this episode we look at option in the metastatic and advanced setting.
